Characterization, in vitro release, and pharmacokinetics of rupestonic acid derivative nanostructured lipid carriers optimized by Box-Behnken design
- 20 November 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (2) , 104070
Abstract
No abstract availableKeywords
Funding Information
- Xinjiang Uygur Autonomous Region Natural Science Foundation (2024D01E33)
This publication has 32 references indexed in Scilit:
- Enhancing cannabidiol bioaccessibility using ionic liquid as emulsifier to produce nanosystems: Characterization of structures, cytotoxicity assessment, and in vitro digestionFood Research International, 2024
- Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorptionInternational Journal of Pharmaceutics, 2020
- Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicityInternational Journal of Biological Macromolecules, 2020
- Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug releaseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Chemical Constituents of Artemisia rupestrisChemistry of Natural Compounds, 2017
- Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complexInternational Journal of Pharmaceutics, 2017
- Size-exclusive effect of nanostructured lipid carriers on oral drug deliveryInternational Journal of Pharmaceutics, 2016
- Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon responseFree Radical Biology and Medicine, 2016
- Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometryAdvanced Drug Delivery Reviews, 2016
- Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptakeInternational Journal of Pharmaceutics, 2011